IMLFF - developing cannabis based therapies
Seite 1 von 1 Neuester Beitrag: 25.04.21 02:59 | ||||
Eröffnet am: | 13.01.17 19:35 | von: JuExCa | Anzahl Beiträge: | 16 |
Neuester Beitrag: | 25.04.21 02:59 | von: Angelikaxvig. | Leser gesamt: | 10.683 |
Forum: | Hot-Stocks | Leser heute: | 5 | |
Bewertet mit: | ||||
InMed Pharmaceuticals Inc. is a biopharmaceutical company specializing in developing cannabis based therapies through the Research and Development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. The company is utilizing its proprietary Intelligent Cannabinoid Drug Design Platform "IDP" to identify new bioactive compounds within the cannabis plant that interact with certain gene targets responsible for specific diseases. Our extensive research and new intellectual properties will initially be focused on the development of several new cannabinoid based treatments for Ocular, Cancer, Inflammation, Pain & Arthritis disease areas.
http://www.otcmarkets.com/stock/IMLFF/profile
**********************************************
Four Long Term Penny Stock Picks For A Profitable 2017
Jan. 12, 2017 2:55 PM ET
http://seekingalpha.com/instablog/...enny-stock-picks-profitable-2017
**********************************************
A Short Term Play With 100% Gain Potential
December 10th, 2016
http://www.otcmarkets.net/short-term-alert/...ith-100-gain-potential/
Updated Target 01/13/2017 : 0.40
http://www.otcmarkets.com/stock/IMLFF/profile
**********************************************
Four Long Term Penny Stock Picks For A Profitable 2017
Jan. 12, 2017 2:55 PM ET
http://seekingalpha.com/instablog/...enny-stock-picks-profitable-2017
**********************************************
A Short Term Play With 100% Gain Potential
December 10th, 2016
http://www.otcmarkets.net/short-term-alert/...ith-100-gain-potential/
Updated Target 01/13/2017 : 0.40
InMed Pharmaceuticals Appoints Martin Bott to Board of Directors
PR Newswire
VANCOUVER, Jan. 13, 2017
CSE: IN
OTCQB: IMLFF
http://www.otcmarkets.com/stock/IMLFF/news/...ctors?id=148598&b=y
PR Newswire
VANCOUVER, Jan. 13, 2017
CSE: IN
OTCQB: IMLFF
http://www.otcmarkets.com/stock/IMLFF/news/...ctors?id=148598&b=y
Jan. 17, 2017
Dundee Capital Markets: Medical Marijuana Conference
https://www.inmedpharma.com/investors/events/
Dundee Capital Markets: Medical Marijuana Conference
https://www.inmedpharma.com/investors/events/
InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for C$1,500,000
Jan. 18, 2017
https://www.inmedpharma.com/news-media/news/2017/...-for-c-1-500-000/
Jan. 18, 2017
https://www.inmedpharma.com/news-media/news/2017/...-for-c-1-500-000/
IMLFF — OTCQB Certification
Published: Jan 23, 2017
http://www.otcmarkets.com/...lReportViewer?symbol=IMLFF&id=165456
Published: Jan 23, 2017
http://www.otcmarkets.com/...lReportViewer?symbol=IMLFF&id=165456
InMed Pharmaceuticals to Present at the 2017 BIO CEO & Investor Conference
Feb. 9, 2017
http://www.tmxmoney.com/en/news/company_releases /news_full.html?file=201702091420CANADANWCANADAPR_C2972
Feb. 9, 2017
http://www.tmxmoney.com/en/news/company_releases /news_full.html?file=201702091420CANADANWCANADAPR_C2972
NetworkNewsWire Announces Publication of Discussion on the R&D of Cannabinoids for Medical Use
Mar 16, 2017
http://web.tmxmoney.com/...wsid=6810111581391150&qm_symbol=IN:CNX
Mar 16, 2017
http://web.tmxmoney.com/...wsid=6810111581391150&qm_symbol=IN:CNX
InMed Pharmaceuticals Files Provisional Patent Application for Ophthalmic Drug Delivery
May 10, 2017
http://www.otcmarkets.com/stock/IMLFF/news/...ivery?id=158612&b=y
May 10, 2017
http://www.otcmarkets.com/stock/IMLFF/news/...ivery?id=158612&b=y
InMed Files Provisional Patent for Biosynthesis of Cannabinoids
Sep 12, 2017
http://www.otcmarkets.com/stock/IMLFF/news/...noids?id=169491&b=y
Sep 12, 2017
http://www.otcmarkets.com/stock/IMLFF/news/...noids?id=169491&b=y